Insights into Company

Shree Cement ↗

📍 Beawar, Rajasthan, India Active NSE SHREECEM CIN L26943RJ1979PLC001935 Cement, Building Materials & Polymers
Search companies

Key Metrics of Shree Cement

Revenue₹19,311 Cr▲ 7.1% YoYFY 2025-26
EBITDA₹4,788 Cr▲ 8.5% YoY
Net profit₹1,706 Cr▲ 42.6% YoY
Net worth₹22,512 Cr▲ 6.1% YoY
Competitors10identified

About Shree Cement

Sectors

Cement, Building Materials & PolymersCement

Company details

Website
shreecement.com
Registered office
Bangur Nagar, Beawar, In-rj, 305901
Listed
NSE: SHREECEM · ₹22,735.00

Operational Areas of Shree Cement

Cement, Building Materials & Polymers›Cement

Company summary

Entity details

CINL26943RJ1979PLC001935
LEI code335800W6FNBDUZ89L830
State codeRJ
PIN code305901
Current legal nameSHREE CEMENT
Classification—
Listing statusListed (NSE: SHREECEM)
Registration no.001935
Company age—
PAN—
CountryIndia
CityBeawar
StateRajasthan
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code26943
Description of main activityManufacture of other non-metallic mineral products (cement, glass, ceramics)
Description of business activityManufacture of other non-metallic mineral products (cement, glass, ceramics)
SectorCement, Building Materials & Polymers · Cement
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 5 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 35 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 03 Jul 2026 CARE AAA Stable outlook · Short term A1+ · Reaffirmed
Change in last 12 monthsNo change
Change since first rating on recordNo changesince Jan 2018
Rating actions180 up · 0 down
Liquidity (CARE)Superior

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
03 Jul 2026CAREReaffirmed AAAA1+Stable₹7,295 Cr View
09 Oct 2025CAREReaffirmed AAAA1+Stable₹7,295 Cr View
10 Oct 2024CAREReaffirmed AAAA1+Stable₹5,250 Cr View
27 Dec 2023CAREReaffirmed AAAA1+Stable₹4,450 Cr View
11 Aug 2023CAREReaffirmed AAAA1+Stable₹3,650 Cr View
05 Jul 2023CAREOther ———— View
13 Jun 2023CAREReaffirmed —A1+—₹500 Cr View
12 Jan 2023CAREReaffirmed —A1+—₹800 Cr View
26 Dec 2022CAREOther ———— View
29 Sep 2022CAREReaffirmed AAAA1+Stable₹2,450 Cr View
22 Sep 2022CAREReaffirmed AAAA1+Stable₹400 Cr View
24 Sep 2021CAREReaffirmed AAAA1+Stable₹400 Cr View
15 Dec 2020CAREOther ———— View
28 Sep 2020CAREReaffirmed AAAA1+Stable₹4,200 Cr View
07 Jan 2020CAREReaffirmed AAAA1+Stable₹1,900 Cr View
27 Dec 2018CAREReaffirmed —A1+—₹600 Cr View
12 Dec 2018CAREReaffirmed AAAA1+Stable₹4,600 Cr View
22 Jan 2018CAREOther ———— View

Credit strengths (CARE, Jul 2026)

+ Strong competitive position supported further by diversified geographical profile

SCL is among top three cement manufacturers in India with its 69.30 MTPA cement capacity as on March 31, 2026, underpinning its strong market position. Already entrenched as a strong player in northern India deriving ~38-39% of its sales volume, SCL has been gradually diversifying its geographical presence. It generates ~27-28% sales volume from the eastern region and ~17% from the central region. West and south India generate modest sales volume. The company has 33.80 MTPA of cement capacities

+ Large retail trade mix driven by healthy brand recall and established distribution network

Despite being a commoditised business, SCL has been able to establish its brand over the years. The company has diversified brand portfolio, consisting of Jungrodhak, Rockstrong, Powermax, Magna , and Roofon. SCL has a dealer base of 20,256 for selling cement to end-customers as on March 31, 2025. The company largely sells blended cement, which is consumed by retail trade segment. The company’s retail trade mix is 64% (73%) in FY26 (FY25) in overall volumes. The company has been focussing on

+ Sound operating efficiencies

The company’s large scale of operations is supported by its internal operating efficiencies allowing it to control costs and have a wide market reach. The company has established captive thermal power plant (TPP) of 503 MW, WHRS (Waste Heat Recovery System) of 296 MW, and renewable energy (solar and wind energy) of 370 MW as on March 31, 2026. This makes the company self-sufficient for significant portion of its power requirements and being cost effective. With 666 MW of captive green power

Credit challenges

− Cyclicality of the cement industry

The cement industry is highly cyclical and depends largely on the country’s economic growth. There is a high degree of correlation between the GDP growth and growth in cement consumption. Being a cyclical industry, the cement sector goes through phases of ups and downs, and accordingly, impacts unit realisations. Exposure to volatile input costs and price realisations The company is exposed to commodity price risk, arising from raw material price fluctuation (gypsum, fly ash, and slag) and fuel

− Exposure to volatile input costs and price realisations

The company is exposed to commodity price risk, arising from raw material price fluctuation (gypsum, fly ash, and slag) and fuel (coal and pet coke). Coal (indigenous and international) is used for power generation to run its plants and fuel for kilns. In the recent past, the cement industry witnessed significant spike in power and fuel costs; post pent-up demand for fuel after multiple COVID-19 waves. Russia-Ukraine war exacerbated fuel cost in FY22 and FY23. Spike in fuel costs impacted profit

Could lead to a downgrade

• Decline in the operating performance, resulting in net debt to profit before interest, lease rentals, depreciation , and taxation (PBILDT) above 1x on a sustained basis. • Significant reduction in the company’s

Agency-reported financials (CARE, 03 Jul 2026)

MetricMarch 31, 2025March 31, 2026
Total operating income₹19,251 Cr₹20,787 Cr
PBILDT*₹3,932 Cr₹4,570 Cr
Profit after tax (PAT)₹1,124 Cr₹1,749 Cr
Overall gearing (x)0.10×0.13×
Interest coverage (x)19.19×21.59×
Revenue growth (YoY)—8.0%
PAT margin5.8%8.4%

Borrowings & rated debt

Rated borrowing limits (latest)₹7,295 Cr
Peak rated limits₹7,295 CrOct 2025 · CARE
Limits raised0 times4 new facilities rated
Weighted average coupon7.07%

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long-term bank facilitiesWorking capital & bank lines—₹3,095 Cr— AAA (Stable)ReaffirmedCARE
Short-term bank facilitiesWorking capital & bank lines—₹2,500 Cr— A1+ReaffirmedCARE
IssuerOther—₹0— AAA (Stable)AssignedCARE
Non-convertible debenturesDebentures & bonds—₹700 Cr— AAA (Stable)ReaffirmedCARE
Commercial paperCommercial paper—₹500 Cr— A1+ReaffirmedCARE
Commercial paperCommercial paper—₹500 Cr— A1+ReaffirmedCARE

Debt instruments

ISINInstrumentTypeCouponIssuedMaturityAmountRatingStatus
INE070A07061Sep OctDebentures & bonds— —— ₹700 CrAAA Not stated
INE070A14703—Commercial paper7.18% —— ₹200 CrA1+ Not stated
INE070A14711—Commercial paper6.95% —— ₹100 CrA1+ Not stated
INE070A14729—Commercial paper6.95% —— ₹100 CrA1+ Not stated
INE070A14612Commercial paper . . +Commercial paper5.28% —— ₹100 CrA1+ Not stated
INE070A14638Commercial paper . . +Commercial paper5.28% —— ₹100 CrA1+ Not stated
INE070A14646Commercial paper . . +Commercial paper5.85% —— ₹100 CrA1+ Not stated
INE070A14828Commercial +Commercial paper5.85% 22 Sep 202522 Dec 2025 ₹175 CrA1+ Matured
INE070A14836Commercial +Commercial paper5.87% 23 Sep 202518 Dec 2025 ₹100 CrA1+ Matured
INE070A14844Commercial +Commercial paper5.87% 23 Sep 202512 Dec 2025 ₹75.0 CrA1+ Matured
INE070A14760Commercial Paper +Commercial paper6.87% 19 Jul 202321 Sep 2023 ₹100 CrA1+ Matured
INE070A14752Commercial Paper +Commercial paper6.97% 20 Jun 202318 Sep 2023 ₹100 CrA1+ Matured
INE070A14745Commercial Paper +Commercial paper7.00% 13 Jun 202311 Sep 2023 ₹100 CrA1+ Matured
INE070A14737Commercial Paper +Commercial paper7.00% 13 Jun 202321 Aug 2023 ₹100 CrA1+ Matured

CARE ratings on record (checked 24 Oct 2026)

InstrumentAmountRating
BG/LC₹2,500 CrCARE A1+
Cash Credit₹3,000 CrCARE AAA; Stable
Commercial Paper (Standalone)₹1,000 CrCARE A1+
Issuer Ratings—CARE AAA; Stable
Issuer Ratings—Withdrawn
Non Convertible Debentures—Withdrawn
Non Convertible Debentures₹700 CrCARE AAA; Stable
Term Loan₹95.4 CrCARE AAA; Stable

Lenders

Fund-based - LTCash CreditAxis Bank Ltd.
Fund-based - LTCash CreditDBS Bank India Ltd.
Fund-based - LTCash CreditHDFC Bank Ltd.
Fund-based - LTCash CreditICICI Bank Ltd.
Fund-based - LTCash CreditJ.P. Morgan Chase Bank N.A.
Fund-based - LTCash CreditKotak Mahindra Bank Ltd.
Fund-based - LTCash CreditMUFG Bank Ltd.
Fund-based - LTCash CreditProposed
Fund-based - LTCash CreditStandard Chartered Bank
Fund-based - LTCash CreditState Bank of India
Fund-based - LTCash CreditSumitomo Mitsui Banking Corporation
Fund-based - LTCash CreditYes Bank Ltd.
Fund-based - LTTerm LoanProposed
Non-fund-based - STBG/LCAxis Bank Ltd.
Non-fund-based - STBG/LCDBS Bank Limited
Non-fund-based - STBG/LCHDFC Bank Ltd.
Non-fund-based - STBG/LCICICI Bank Ltd.
Non-fund-based - STBG/LCJ.P. Morgan Chase Bank N.A.
Non-fund-based - STBG/LCKotak Mahindra Bank Ltd.
Non-fund-based - STBG/LCMUFG Bank Ltd.
Non-fund-based - STBG/LCStandard Chartered Bank
Non-fund-based - STBG/LCState Bank of India
Non-fund-based - STBG/LCSumitomo Mitsui Banking Corporation

Credit assessment · Cement

CARE Ratings’ Criteria for Rating Cement Companies (Sep 2024) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityAdequateAgency: Superior
DirectionStableAgency outlook: Stable
CARE rating · Jul 2026AAAMatches indicative band

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)94%
Information on file78% · missing: Capex / investment plans, Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding likely Next rating action stable or better: 90% (Stable or improving) · ML model on 4072 rating histories, AUC 0.666
Rated limits₹7,295 Cr
Not yet allocated—
Extra debt within 3.5× EBITDA—
Interest coverage21.59×
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 90% chance the next rating action is stable or better
  • Current rating AAA (investment grade)
  • Interest coverage 21.59×

Rated limits by facility

Timeline

03 Jul 2026 CARE reaffirmed: AAA (Stable)Rated limits ₹7,295.42 cr CARE rationale
03 Jul 2026 Cash & liquid funds ₹248 cr
From the report

The company had free cash and cash equivalents of ₹248 crore as on March 31, 2026, while current investments were ₹8352 crore.

CARE rationale
09 Oct 2025 CARE reaffirmed: AAA (Stable)Rated limits ₹7,295.42 cr CARE rationale
09 Oct 2025 Cash & liquid funds ₹221 cr
From the report

The company had free cash & cash equivalents of ₹221 crore as on March 31, 2024, while investments were ₹7849 crore.

CARE rationale
10 Oct 2024 CARE reaffirmed: AAA (Stable)Rated limits ₹5,250 cr CARE rationale
10 Oct 2024 Cash & liquid funds ₹277 cr
From the report

The company had free cash & cash equivalents of ₹277 crore as on March 31, 2024, while investments were ₹7556 crore.

CARE rationale
27 Dec 2023 CARE reaffirmed: AAA (Stable)Rated limits ₹4,450 cr CARE rationale
27 Dec 2023 Cash & liquid funds ₹3,058 cr
From the report

The company had generated gross cash accrual of ₹3058 crore in FY23.

CARE rationale
27 Dec 2023 Cash & liquid funds ₹1,771 cr
From the report

The company has already achieved gross cash accruals of Rs.1771 crore in H1FY24.

CARE rationale
27 Dec 2023 Cash & liquid funds ₹228 cr
From the report

The company had free cash & cash equivalents of ₹228 crore as on Sept 30, 2023 and while investments were Rs.8052 cr.

CARE rationale
11 Aug 2023 CARE reaffirmed: AAA (Stable)Rated limits ₹3,650 cr CARE rationale
11 Aug 2023 Cash & liquid funds ₹3,058 cr
From the report

The company had generated gross cash accrual of Rs.3058 crore in FY23.

CARE rationale
11 Aug 2023 Cash & liquid funds ₹51.69 cr
From the report

The company had free cash & cash equivalents of Rs.51.69 crore as on March 31, 2023 and while investments were Rs.8683 cr.

CARE rationale
11 Aug 2023 ₹700 cr of limits rated but not yet allocated to a lender CARE rationale
05 Jul 2023 CARE other: — CARE rationale
13 Jun 2023 CARE reaffirmed: A1+Rated limits ₹500 cr CARE rationale
13 Jun 2023 Cash & liquid funds ₹161 cr
From the report

SCL had significant investments in bonds, mutual funds, etc, to the tune of ₹8,683 crore as on March 31, 2023 along with cash and balances of ₹161 crore.

CARE rationale
12 Jan 2023 CARE reaffirmed: A1+Rated limits ₹800 cr CARE rationale
12 Jan 2023 Cash & liquid funds ₹2,800 cr
From the report

The debt repayment obligation for SCL in FY23 stands at ₹378.92 crore against expected gross cash accruals (GCA) of over ₹2,800 crore in FY23 (out of which ₹189 crore is left, which is due in Q4FY23).

CARE rationale
12 Jan 2023 Cash & liquid funds ₹7,060 cr
From the report

SCL (standalone)’s liquid investment/unencumbered cash and bank balance stood at ₹7,060 crore as on December 31, 2022.

CARE rationale
26 Dec 2022 CARE other: — CARE rationale
29 Sep 2022 CARE reaffirmed: AAA (Stable)Rated limits ₹2,450 cr CARE rationale
29 Sep 2022 New borrowing arranged (commercial paper)
From the report

Reaffirmed Outlook: Stable] 0.00 Total Instrument (₹ Only) Commercial Paper (Carved CARE A1+ 400.00 Reaffirmed out) * (A One Plus) Total Short Term 400.00 Instruments (₹ Four Hundred Crore Only) Details of instruments/facilities in Annexure-1. *Carved out of sanctioned working capital limits of the company.

CARE rationale
29 Sep 2022 Cash & liquid funds ₹2,800 cr
From the report

The debt repayment obligation for SCL in FY23 stands at ₹378.92 crore against expected gross cash accruals (GCA) of over ₹2,800 crore in FY23.

CARE rationale
29 Sep 2022 Cash & liquid funds ₹7,060 cr
From the report

SCL (standalone)’s liquid investment/unencumbered cash and bank balance stood at ₹7,060 crore as on June 30, 2022.

CARE rationale
22 Sep 2022 CARE reaffirmed: AAA (Stable)Rated limits ₹400 cr CARE rationale
22 Sep 2022 New borrowing arranged (commercial paper)
From the report

Reaffirmed Outlook: Stable] 0.00 Total instrument (₹ only) Commercial paper (Carved CARE A1+ 400.00 Reaffirmed out)* (A One Plus) Total short-term 400.00 instruments (₹ Four hundred crore only) Details of instruments/facilities in Annexure-1. *Carved out of sanctioned working capital limits of the company.

CARE rationale
22 Sep 2022 Cash & liquid funds ₹2,800 cr
From the report

The debt repayment obligation for SCL in FY23 stands at ₹378.92 crore against expected gross cash accruals(GCA) of over ₹2,800 crore in FY23.

CARE rationale
22 Sep 2022 Cash & liquid funds ₹7,060 cr
From the report

SCL (standalone)’s liquid investment/unencumbered cash and bank balance stood at ₹7,060 crore as on June 30, 2022.

CARE rationale
24 Sep 2021 CARE reaffirmed: AAA (Stable)Rated limits ₹400 cr CARE rationale
24 Sep 2021 New borrowing arranged (term loans)
From the report

Four hundred crore only) Details of instruments/facilities in Annexure -1 *Carved out of the sanctioned working capital limits of the company ^The Issuer Rating would be subject to Overall gearing not exceeding 0.25 times as on March 31, 2022. *The aggregate of CP and other working capital borrowings shall be within the sanctioned working capital limits.

CARE rationale
24 Sep 2021 Cash & liquid funds ₹8,581 cr
From the report

During FY21, the company met its entire capex funding through internal accruals and still maintained comfortable cash and liquid investments at Rs.8,581 crore as on March 31, 2021 (standalone basis).

CARE rationale
24 Sep 2021 Cash & liquid funds ₹9,209 cr
From the report

On consolidated basis, total cash & equivalents stood at Rs.9,209 crore.

CARE rationale
24 Sep 2021 Cash & liquid funds ₹3,000 cr
From the report

The deb t repayment obligation for SCL (standalone) FY22 stands at Rs.294 crore against expected gross cash accruals of over Rs.3,000 crore in FY22.

CARE rationale
24 Sep 2021 Cash & liquid funds ₹6,947 cr
From the report

SCL (standalone)’s unencumbered cash and bank balance (including liquid investments) stood at Rs.6,947 crore as on June 30, 2021.

CARE rationale
15 Dec 2020 CARE other: — CARE rationale
15 Dec 2020 Cash & liquid funds ₹5,939 cr
From the report

Despite, substantial increase in term loan in FY18 for the Kodala integrated unit (term loan of Rs.1613), the solvency ratio of the company remains comfortable marked by high unencumbered cash and liquid investments of Rs.5939 crore as on September 30, 2020 against total debt of Rs.2953 crore (including security deposits from customers).

CARE rationale
15 Dec 2020 ₹2,400 cr raised
From the report

The company had raised Rs.2400 crores in November 2019 through qualified institutional buyers for pursuing organic growth opportunities.

CARE rationale
28 Sep 2020 CARE reaffirmed: AAA (Stable)Rated limits ₹4,200 cr CARE rationale
28 Sep 2020 Cash & liquid funds ₹6,089 cr
From the report

Despite, substantial increase in term loan in FY18 for the Kodala integrated unit (term loan of Rs.1613), the solvency ratio of the company remains comfortable marked by high unencumbered cash and liquid investments of Rs.6089 crore as on June 30, 2020 against total debt of Rs.3366 crore (including security deposits from customers).

CARE rationale
28 Sep 2020 ₹2,400 cr raised
From the report

The company had raised Rs.2400 crores in November 2019 through qualified institutional buyers for pursuing organic growth opportunities.

CARE rationale
07 Jan 2020 CARE reaffirmed: AAA (Stable)Rated limits ₹1,900 cr CARE rationale
07 Jan 2020 ₹2,400 cr raised through equity
From the report

Six hundred crore only) (A One Plus) Details of facilities in Annexure-1 Detailed Rationale & Key Rating Drivers The ratings assigned to the bank facilities and instruments of Shree Cement Limited (SCL) continue to derive strength from rich experience of the promoters and qualified management team, sizeable portfolio of surplus funds amounting to around Rs.6,000 crores as on December 13, 2019 despite continuous capacity expansion, strong financial risk profile as on last 3 account closing dates including QIP issue of Rs.2400 crores in November 2019, improvement in the power segment in FY19, st

CARE rationale
07 Jan 2020 Cash & liquid funds ₹3,303 cr
From the report

Despite, substantial increase in term loan in FY18 for the Kodala integrated unit (term loan of Rs.1613), the solvency ratio of the company remains comfortable marked by high cash and liquid investments of Rs.3303 crore as on 30th September 2019 (Rs.6,000 crores as on 13th December 2019) against total debt of Rs.3405 crore.

CARE rationale
07 Jan 2020 Debt repayments due in FY19: ₹9 cr
From the report

The Company has earned GCA of Rs.2255 crore in FY19 and Rs.1439 crore in H1FY20 against a debt repayment obligation of Rs. 9 crore in FY19 and Rs. 69 crore in FY20 (Full amount was paid in April 2019).

CARE rationale
27 Dec 2018 CARE reaffirmed: A1+Rated limits ₹600 cr CARE rationale
27 Dec 2018 New borrowing arranged (commercial paper)
From the report

Six Hundred crore only) Details of instruments/facilities in Annexure-1 $The aggregate of CP and other working capital borrowings shall be within the sanctioned working capital limits Detailed Rationale & Key Rating Drivers The ratings assigned to commercial paper instruments of Shree Cement Limited (SCL) continue to derive strength from rich experience of the promoters and qualified management team, sizeable portfolio of surplus funds despite continuous capacity expansion, strong financial risk profile and operating efficiency resulting in the company being the low cost producer of cement and

CARE rationale
27 Dec 2018 New borrowing arranged (term loans)
From the report

The total debt/GCA as on March 31, 2018was comfortable at 1.12x vis-à-vis 0.42x as on March 30, 2017 despite substantial term loan was disbursed during year end,.

CARE rationale
27 Dec 2018 New borrowing arranged: ₹2,815 cr (term loans)
From the report

The company had cash, bank and liquid investments of Rs.2815 crore as on Sep 30, 2018 vis-à-vis Rs.5755 crore (including disbursed loan of Rs.1613 crore for Kodla Unit) as on March 31, 2018, due to the aforementioned factors.

CARE rationale
27 Dec 2018 Cash & liquid funds ₹2,815 cr
From the report

The company had cash, bank and liquid investments of Rs.2815 crore as on Sep 30, 2018 vis-à-vis Rs.5755 crore (including disbursed loan of Rs.1613 crore for Kodla Unit) as on March 31, 2018, due to the aforementioned factors.

CARE rationale
27 Dec 2018 Debt repayments due: ₹8.99 cr
From the report

The company earned a GCA of Rs. 842.78 crore in H1FY19 against a debt repayment obligation of Rs.8.99 crore during the year.

CARE rationale
12 Dec 2018 CARE reaffirmed: AAA (Stable)Rated limits ₹4,600 cr CARE rationale
12 Dec 2018 New borrowing arranged (term loans)
From the report

The total debt/GCA as on March 31, 2018was comfortable at 1.12x vis-à-vis 0.42x as on March 30, 2017 despite substantial term loan was disbursed during year end,.

CARE rationale
12 Dec 2018 New borrowing arranged: ₹2,815 cr (term loans)
From the report

The company had cash, bank and liquid investments of Rs.2815 crore as on Sep 30, 2018 vis-à-vis Rs.5755 crore (including disbursed loan of Rs.1613 crore for Kodla Unit) as on March 31, 2018, due to the aforementioned factors.

CARE rationale
12 Dec 2018 Cash & liquid funds ₹2,815 cr
From the report

The company had cash, bank and liquid investments of Rs.2815 crore as on Sep 30, 2018 vis-à-vis Rs.5755 crore (including disbursed loan of Rs.1613 crore for Kodla Unit) as on March 31, 2018, due to the aforementioned factors.

CARE rationale
12 Dec 2018 Debt repayments due: ₹8.99 cr
From the report

The company earned a GCA of Rs. 842.78 crore in H1FY19 against a debt repayment obligation of Rs.8.99 crore during the year.

CARE rationale
12 Dec 2018 ₹500 cr of limits rated but not yet allocated to a lender CARE rationale
22 Jan 2018 CARE other: — CARE rationale
22 Jan 2018 Cash & liquid funds ₹4,000 cr
From the report

As on December 31,2017, SCL’s aggregate investment in liquid investments stood at around Rs.4,000 crore.

CARE rationale
22 Jan 2018 Cash & liquid funds ₹1,657.41 cr
From the report

Moreover, during 9MFY18 (April to December 2017), SCL earned a cash profit of Rs.1,657.41 crore.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeBANGUR NAGAR, BEAWAR, IN-RJ, 305901
GSTIN—
Email—
Websitehttps://www.shreecement.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Shree Cement

Competitors10identified
Locations3most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
UltraTech Cement Cement · Cement, Building Materials & Polymers ultratechcement.com 1983 Mumbai, India
Ambuja Cements Cement · Cement, Building Materials & Polymers ambujacement.com — Ahmedabad, India
ACC Cement · Cement, Building Materials & Polymers acclimited.com — Gandhinagar, India
Dalmia Bharat Cement · Cement, Building Materials & Polymers dalmiacement.com — Tiruchirapalli, India
JK Cement Cement · Cement, Building Materials & Polymers jkcement.com — Rajasthan, India
Nuvoco Vistas Cement · Cement, Building Materials & Polymers nuvoco.com — Mumbai, India
Birla Corporation Limited Discovered Companies · Other Industries birlacorporation.com — Kolkata, West Bengal, India
The Ramco Cements Cement · Cement, Building Materials & Polymers ramcocements.in — Rajapalayam, India
Prism Johnson Limited Tiles & Ceramics · Cement, Building Materials & Polymers prismjohnson.in — Hyderabad, India
Jk Lakshmi Cement Limited Cement · Cement, Building Materials & Polymers jklakshmicement.com — Rajasthan, Delhi, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Cement

Filings

No filings on record yet.